GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

in combination with chemotherapy as a first-line option for certain forms of gastric or gastroesophageal carcinoma. Specifically, the anti-PD-1 monoclonal antibody will therefore be available in ...

Gastric cancer, commonly known as stomach cancer, is the fifth most common cancer globally and the fifth leading cause of ...

1 According to the American Cancer Society, gastric cancer accounts for 1.5% of all cancers in the United States. It is most common in people over 65 years of age, with a median diagnosis age of 68 ...

esophageal carcinoma, gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma. The approval was based on the multicenter, randomized, open-label CHECKMATE-67T trial ...